ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 205.1 CNY | -0.85% |
|
-4.35% | -15.26% |
| Jun. 21 | Pientzehuang Pharmaceutical Gets Nod to Trails Lymphoma Drug | MT |
| Apr. 19 | Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ETFs positioned on Zhangzhou Pientzehuang Pharmaceutical., Ltd
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.00% | 1 M€ | -23.80% | - | |
| 2.49% | 2 M€ | -14.14% | ||
| 0.27% | 35 M€ | -5.85% | - | |
| 0.17% | 4 M€ | -11.56% | ||
| 0.03% | 11 M€ | +8.06% | ||
| 0.02% | 451 M€ | +9.33% | - | |
| 0.02% | 2,838 M€ | +12.59% | - | |
| 0.02% | 152 M€ | +9.39% | - | |
| 0.02% | 114 M€ | +7.19% | - | |
| 0.02% | 4 M€ | -4.41% | - | |
| 0.00% | 35 M€ | +6.43% | - | |
| 0.00% | 7 M€ | +5.07% | - | |
| 0.00% | 414 M€ | +12.21% | - | |
| 0.00% | 36 M€ | +10.41% | - | |
| 0.00% | 32 M€ | +5.00% | - | |
| 0.00% | 40 M€ | +7.08% | - | |
| 0.00% | 324 M€ | +8.65% | - | |
| 0.00% | 17 M€ | +3.30% | - | |
| 0.00% | 104 M€ | +5.63% | - | |
| 0.00% | 55 M€ | +1.59% | - |
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. is specialized in developing and marketing traditional Chinese medicine products. The company offers medicines and health products, cosmetic products, dietary compounds, etc.
Sector
Pharmaceuticals
Calendar
2024-08-18
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
205.1
CNY
Average target price
285.8
CNY
Spread / Average Target
+39.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.26% | 17.02B | |
| +54.07% | 809B | |
| +38.33% | 621B | |
| -7.05% | 351B | |
| +15.44% | 319B | |
| +5.72% | 289B | |
| +14.36% | 238B | |
| -1.27% | 221B | |
| +13.77% | 218B | |
| +7.42% | 166B |
- Stock Market
- Equities
- 600436 Stock
- ETFs Zhangzhou Pientzehuang Pharmaceutical., Ltd
